In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.

Whether ahead of their time, truly bizarre, or just plain doomed, it’s certainly interesting to see companies go completely ...

Inari raised $144 million to bring gene-edited seeds to market and an Israel-based startup looks to develop its computer ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...

Bayer said Thursday it has acquired camelina germplasm, intellectual property, and materials from Smart Earth Camelina Corp.

Bayer's projected earnings decline and litigation pressures affect its outlook. Find out why BAYRY stock might face ...

Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) announced Thursday that elinzanetant, its experimental therapy for hot flashes, reached the ...

With their grip on the industry’s intellectual property, Bayer and Corteva also control the majority of the market for corn ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

Leading up to launch, Bayer will work with Neste, the value chain, and farmers to introduce winter canola as a biomass-based ...